SyNoesis Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

SyNoesis Therapeutics General Information

Description

Operator of a biotechnology company intended for the development of precision therapeutics and digital biomarkers for chronic diseases. The company operates at the intersection of nuclear receptor pharmacology, translational biomarker development, clinical artificial intelligence, and regulatory-grade drug development, enabling clients to identify and intervene in disease progression before irreversible damage occurs.

Contact Information

Website
www.synoesis-therapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 100, North Plastira Street
  • Crete
  • Heraklion
  • Greece
+30 694
Primary Industry
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 100, North Plastira Street
  • Crete
  • Heraklion
  • Greece
+30 694

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SyNoesis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 23-Apr-2026 Completed Generating Revenue
3. Accelerator/Incubator 01-Apr-2026 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 06-Dec-2018 $22.7K Completed Generating Revenue
To view SyNoesis Therapeutics’s complete valuation and funding history, request access »

SyNoesis Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator
StartSmart South Eastern Europe Accelerator/Incubator
EIT Health Accelerator/Incubator
Gold Track Accelerator/Incubator
To view SyNoesis Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

SyNoesis Therapeutics FAQs

  • When was SyNoesis Therapeutics founded?

    SyNoesis Therapeutics was founded in 2017.

  • Where is SyNoesis Therapeutics headquartered?

    SyNoesis Therapeutics is headquartered in Heraklion, Greece.

  • What industry is SyNoesis Therapeutics in?

    SyNoesis Therapeutics’s primary industry is Biotechnology.

  • Is SyNoesis Therapeutics a private or public company?

    SyNoesis Therapeutics is a Private company.

  • What is SyNoesis Therapeutics’s current revenue?

    The current revenue for SyNoesis Therapeutics is .

  • Who are SyNoesis Therapeutics’s investors?

    European Innovation Council, StartSmart South Eastern Europe, EIT Health, and Gold Track have invested in SyNoesis Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process